Levodopa Administration and Multiple Primary Cutaneous Melanomas
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Modification of Parkinsonism — Chronic Treatment with L-Dopa
1969 • 1,253 citations
Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis
1953 • 988 citations
Origin of Familial Malignant Melanomas From Heritable Melanocytic Lesions
1978 • 808 citations
L-Dopa: Selective Toxicity for Melanoma Cells in Vitro
1977 • 159 citations
The evolution of concepts of melanin biology.
1967 • 133 citations
The Toxicity of Melanin Precursors
1978 • 130 citations
Molecular biology of pigment cells. Molecular controls in mammalian pigmentation.
1973 • 121 citations
L-Dopa methyl ester as a new antitumour agent
1977 • 89 citations
Hereditary Aspects of Malignant Melanoma
1967 • 80 citations
Multiple primary melanoma following administration of levodopa.
1972 • 77 citations
Epidermotropically metastatic malignant melanoma. Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis
1978 • 61 citations
Multiple Primary Cutaneous Melanomas
1975 • 53 citations
Levodopa Therapy and Malignant Melanoma
1978 • 48 citations
Levodopa and melanoma
1974 • 40 citations
Familial Factor in Malignant Melanoma
1965 • 37 citations
Selective Toxicity of 6-Hydroxydopa for Melanoma Cells
1979 • 33 citations
Enhancement of L-Dopa Incorporation into Melanoma by Dopa Decarboxylase Inhibition
1978 • 30 citations
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
1977 • 28 citations
Exposure to asbestos and the genesis of pleural plaques and neoplasia.
1973 • 24 citations
5-S-cysteinyldopa in the urine of melanoma patients
1977 • 23 citations
Familial Malignant Melanoma
1963 • 21 citations
Parkinson's Disease: Search for Better Therapies
1979 • 13 citations
Recent developments in Parkinson's disease and Huntington's chorea.
1976 • 9 citations
Cited By (0)
No citing papers found in database